Risk identification and management: MRI as a research tool in toxicology studies of new chemical entities

Progress in Drug Research

Volumn 62, Issue , 2005, Pages 257-278

  Tengowski, Mark W ^a   Kotyk, John J ^b  

^a PFIZER INC   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CISPLATIN; DOXORUBICIN; ERYTHROPOIETIN; GADOLINIUM PENTETATE; VIGABATRIN;

ALZHEIMER DISEASE; BLADDER CANCER; BLOOD SAMPLING; BRAIN EDEMA; BREATHING MECHANICS; CANCER; CARDIOTOXICITY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIFFUSION TENSOR IMAGING; DRUG ABSORPTION; DRUG APPROVAL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDUSTRY; ECHOGRAPHY; ESOPHAGUS CANCER; HISTOPATHOLOGY; HUMAN; IRON OVERLOAD; KIDNEY PERFUSION; LIVER TOXICITY; LUNG CANCER; MAGNETIC RESONANCE ANGIOGRAPHY; MULTIPLE SCLEROSIS; NEPHROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OPTICAL COHERENCE TOMOGRAPHY; OSTEOARTHRITIS; OVARY CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOFREQUENCY; REVIEW; RISK ASSESSMENT; SIGNAL NOISE RATIO; STOMACH CANCER; TESTIS CANCER; THREE DIMENSIONAL IMAGING; TOXICITY TESTING; UREA NITROGEN BLOOD LEVEL;

EID: 27644571581     PISSN: 0071786X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/3-7643-7426-8_7     Document Type: Review

References (74)

1. Spoor F, Jeffery N, Zonneveld F (2000) Using diagnostic radiology in human evolutionary studies. J Anat 197: 61-76
2. Halvorsen RA, Jr., Yee J, McCormick VD (1996) Diagnosis and staging of gastric cancer. Semin Oncol 23: 325-335
3. Woodard PK, Dehdashti F, Putman CE (1998) Radiologie diagnosis of extrathoracic metastases to the lung. Oncology (Huntington) 12: 431-438
4. Nagashima T, Suzuki M, Yagata H, Hashimoto H, Shishikura T, Imanaka N, Ueda T, Miyazaki M (2002) Dynamic-enhanced MRI predicts metastatic potential of invasive ductal breast cancer. Breast Cancer 9: 226-230
5. Kim SG, Ogawa S (2002) Insights into new techniques for high resolution functional MR. Curr Opin Neurobiol 12: 607-615
6. Miller DH, Barkhof F, Frank JA, Parker GJ, Thompson AJ (2002) Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 125: 1676-1695
7. Caviness VS, Jr., Lange NT, Makris N, Herbert MR, Kennedy DN (1999) MRI-based brain volumetrics: emergence of a developmental brain science. Brain Dev 21: 289-295
8. Lawrie SM, Abukmeil SS (1998) Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry 172: 110-120
9. Belozerova I, Shenkman B, Mazin M, Leblanc A (2001) Effects of long-duration bed rest on structural compartments of m. soleus in man. J Gravit Physiol 8: P71-P72
10. Cockman MD, Jones MB, Prenger MC, Sheldon RJ (2001) Magnetic resonance imaging of denervation-induced muscle atrophy: effects of clenbuterol in the rat. Muscle Nerve 24:1647-1658
11. di Cesare E (2003) MRI assessment of right ventricular dysplasia. Eur Radiol 13: 1387-1393
12. Sato M, Yagasaki T, Kora T, Awaya S (1998) Comparison of muscle volume between congenital and acquired superior oblique palsies by magnetic resonance imaging. Jpn J Ophthalmol 42: 466-470
13. Nikolaou K, Poon M, Sirol M, Becker CR, Fayad ZA (2003) Complementary results of computed tomography and magnetic resonance imaging of the heart and coronary arteries: a review and future outlook. Cardiol Clin 21: 639-655
14. Saeed M (2001) New concepts in characterization of ischemically injured myocardium by MRI. Exp Biol Med 226: 367-376
15. Hanni M, Lekka-Banos I, Nilsson S, Haggroth L, Smedby O (1999) Quantitation of atherosclerosis by magnetic resonance imaging and 3-D morphology operators. Magn Reson Imaging 17: 585-591
16. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF (2001) Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 103: 415-422
17. Hockings PD, Roberts T, Galloway GJ, Reid DG, Harris DA, Vidgeon-Hart M, Groot PH, Suckling KE, Benson GM (2002) Repeated three-dimensional magnetic resonance imag-ing of atherosclerosis development in innominate arteries of low-density lipoprotein receptor-knockout mice. Circulation 106: 1716-1721
18. Peterfy CG (1996) MR imaging. Baillieres Clinical Rheumatology 10: 635-678
19. Logothetis NK (2002) The neural basis of the blood-oxygen-level-dependent functional magnetic resonance imaging signal. Phil Trans R Soc Lond 357:1003-1037
20. Detre JA, Wang J (2002) Technical aspects and utility of fMRI using BOLD and ASL. Clin Neurophysiol 113: 621-634
21. Mullins PG, Reid DG, Hockings PD, Hadingham SJ, Campbell CA, Chalk JB, Doddrell DM (2001) Ischaemic preconditioning in the rat brain: a longitudinal magnetic resonance imaging (MRI) study. NMR in Biomedicine 14: 204-209
22. Volz HP, Gaser C, Hager F, Rzanny R, Mentzel HJ, Kreitschmann-Andermahr I, Kaiser WA, Sauer H (1997) Brain activation during cognitive stimulation with the Wisconsin Card Sorting Test-a functional MRI study on healthy volunteers and schizophrenics. Psychiatry Res 75: 145-157
23. Sinha S, Sinha U (2002) Functional magnetic resonance of human breast tumors: diffusion and perfusion imaging. Ann NY Acad Sci 980: 95-115
24. Huber P, Peschke P, Brix G, Hahn EW, Lorenz A, Tiefenbacher U, Wannenmacher M, Debus J (1999) Synergistic interaction of ultrasonic shock waves and hyperthermia in the Dunning prostate tumor R3327-AT1. Int J Cancer 82: 84-91
25. Huisman TA (2003) Diffusion-weighted imaging: basic concepts and application in cerebral stroke and head trauma. Eur Radiol 13: 2283-2297
26. Miller DH, Filippi M, Fazekas F, Frederiksen JL, Matthews PM, Montalban X, Polman CH (2004) Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis. Ann Neurol 56: 273-278
27. Weinmann HJ, Ebert W, Misselwitz B, Schmitt-Willich H (2003) Tissue-specific MR contrast agents. Eur J Radiol 46: 33-44
28. Pearlman JD, Laham RJ, Post M, Leiner T, Simons M (2002) Medical imaging techniques in the evaluation of strategies for therapeutic angiogenesis. Curr Pharm Des 8: 1467-1496
29. Kluge A, Dill T, Ekinci O, Hansel J, Hamm C, Pitschner HF, Bachmann G (2004) Decreased pulmonary perfusion in pulmonary vein stenosis after radiofrequency ablation: assessment with dynamic magnetic resonance perfusion imaging. Chest 126: 428-437
30. Baer FM, Theissen P, Schneider CA, Kettering K, Voth E, Sechtem U, Schicha H (1999) MRI assessment of myocardial viability: comparison with other imaging techniques. Rays 24: 96-108
31. Botnar RM, Perez AS, Witte S, Wiethoff AJ, Laredo J, Hamilton J, Quist W, Parsons EC, Jr, Vaidya A, Kolodziej A et al. (2004) In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation 109: 2023-2029
32. Barber PA, Foniok T, Kirk D, Buchan AM, Laurent S, Boutry S, Muller RN, Hoyte L, Tomanek B, Tuor UI (2004) MR molecular imaging of early endothelial activation in focal ischemia. Ann Neurol 56: 116-120
33. Artemov D (2003) Molecular magnetic resonance imaging with targeted contrast agents. J Cell Biochem 90: 518-524
34. Shapiro EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, Koretsky AP (2004) MRI detection of single particles for cellular imaging. Proc Natl Acad Sci USA 101: 10901-10906
35. Moffat BA, Reddy GR, McConville P, Hall DE, Chenevert TL, Kopelman RR, Philbert M, Weissleder R, Rehemtulla A, Ross BD (2003) A novel polyacrylamide magnetic nanoparticle contrast agent for molecular imaging using MRI. Mol Imaging 2: 324-332
36. Hockings PD, Roberts T, Campbell SP, Reid DG, Greenhill RW, Policy SR, Nelson P, Bertram TA, Kramer K (2002) Longitudinal magnetic resonance imaging quantitation of rat liver regeneration after partial hepatectomy. Toxicol Pathol 30: 606-610
37. Lee BC, Mintun M, Buckner RL, Morris JC (2003) Imaging of Alzheimer's disease. J Neuroimaging 13: 199-214
38. Fuchs VR, Sox HC Jr (2001) Physicians' views of the relative importance of thirty medical innovations. Health Affairs 20: 30-42
39. Awaya H, Ito K, Honjo K, Fujita T, Matsumoto T, Matsunaga N (1998) Differential diagnosis of hepatic tumors with delayed enhancement at gadolinium-enhanced MRI: a pictorial essay. Clin Imaging 22: 180-187
40. Murakami T, Mochizuki K, Nakamura H (2001) Imaging evaluation of the cirrhotic liver. Semin Liver Dis 21: 213-224
41. Beutler E, Hoffbrand AV, Cook JD (2003) Iron deficiency and overload. Hematology: 40-61
42. Mortele KJ, Ros PR (2001) Imaging of diffuse liver disease. Semin Liver Dis 21: 195-212
43. Hockings PD, Changani KK, Saeed N, Reid DG, Birmingham J, O'Brien P, Osborne J, Toseland CN, Buckingham RE (2003) Rapid reversal of hepatic steatosis, and reduction of muscle triglyceride, by rosiglitazone: MRI/S studies in Zucker fatty rats. Metabolism 5: 234-243
44. Zhang X, Tengowski M, Fasulo L, Botts S, Suddarth SA, Johnson GA (2004) Measurement of fat/water ratios in rat liver using 3D three-point dixon MRI. Magn Reson Med 51: 697-702
45. Dixon WT (1984) Simple proton spectroscopic imaging. Radiology 153: 189-194
46. Glover GH (1991) Multipoint Dixon technique for water and fat proton and susceptibility imaging. J Magn Reson Imaging 1: 521-530
47. Glover GH, Schneider E (1991) Three-point Dixon technique for true water/fat decomposition with BO inhomogeneity correction. Magn Reson Med 18: 371-383
48. Rudolph U, Mohler H (2004) Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Ann Rev Pharmacol Toxicol 44: 475-498
49. Vacher CM, Bettler B (2003) GABA(B) receptors as potential therapeutic targets. Curr Drug Target CNS Neurol Disord 2: 248-259
50. Johnston GA, Chebib M, Hanrahan JR, Mewett KN (2003) GABA(C) receptors as drug targets. Curr Drug Target CNS Neurol Disord 2: 260-268
51. Aragon C, Lopez-Corcuera B (2003) Structure, function and regulation of glycine neurotransporters. Eur J Pharmacol 479: 249-262
52. Sonnewald U, Qu H, Aschner M (2002) Pharmacology and toxicology of astrocyte-neuron glutamate transport and cycling. J Pharm Exp Ther 301: 1-6
53. Grant SM, Heel RC (1991) Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Drugs 41: 889-926
54. Sabers A, Gram L (1992) Pharmacology of vigabatrin. Pharmacol Toxicol 70: 237-243
55. Schechter PJ (1989) Clinical pharmacology of vigabatrin. Brit J Clin Pharmacol 27: 19S-22S
56. Summers BA, Cummings JF, de Lahunta A (1995) Hereditary, familial, and idiopathic degenerative diseases. In: N Coon (ed): Veterinary Neuropathology, Mosby-Year Book, Inc., St. Louis, 281-350
57. Malm G, Ringden O, Winiarski J, Grondahl E, Uyebrant P, Eriksson U, Hakansson H, Skjeldal O, Mansson JE (1996) Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow transplantation. Bone Marrow Transplant 17: 1003-1008
58. Matsuyama W, Kuriyama M, Nakagawa M, Kanazawa H, Takenaga S, Ijichi S, Osame M (1996) Choroideremia with leukoencephalopathy and arylsulfatase A pseudodeficiency. J Neurol Sci 138: 161-164
59. Barkhof F, Scheitern P (2002) Imaging of white matter lesions. Cerebrovasc Dis 13: 21-30
60. Jackson GD, Williams SR, Weller RO, van Bruggen N, Preece NE, Williams SC, Butler WH, Duncan JS (1994) Vigabatrin-induced lesions in the rat brain demonstrated by quantitative magnetic resonance imaging. Epilepsy Res 18: 57-66
61. Preece NE, Houseman J, King MD, Weller RO, Williams SR (2004) Development of vigabatrin-induced lesions in the rat brain studied by magnetic resonance imaging, histology, and immunocytochemistry. Synapse 53: 36-43
62. Weiss KL, Schroeder CE, Kastin SJ, Gibson JP, Yarrington JT, Heydorn WE, McBride RG, Sussman NM, Arezzo JC (1994) MRI monitoring of vigabatrin-induced intramyelinic edema in dogs. Neurology 44: 1944-1949
63. Peyster RG, Sussman NM, Hershey BL, Heydorn WE, Meyerson LR, Yarrington JT, Gibson JP (1995) Use of ex vivo magnetic resonance imaging to detect onset of vigabatrin-induced intramyelinic edema in canine brain. Epilepsia 36: 93-100
64. Agosti R, Yasargil G, Egli M, Wieser HG, Wiestler OD (1990) Neuropathology of a human hippocampus following long-term treatment with vigabatrin: lack of microvacuoles. Epilepsy Res 6: 166-170
65. Cohen JA, Fisher RS, Brigell MG, Peyster RG, Sze G (2000) The potential for vigabatrin-induced intramyelinic edema in humans. Epilepsia 41:148-157
66. Vallee JP, Lazeyras F, Khan HG, Terrier F (2000) Absolute renal blood flow quantification by dynamic MRI and Gd-DTPA. Eur Radiol 10: 1245-1252
67. Pedersen M, Shi Y, Anderson P, Stodkilde-Jorgensen H, Djurhuus JC, Gordon I, Frokiaer J (2004) Quantitation of differential renal blood flow and renal function using dynamic contrast-enhanced MRI in rats. Magn Reson Med 51: 510-517
68. Kobayashi H, Kawamoto S, Jo SK, Sato N, Saga T, Hiraga A, Konishi J, Hu S, Togashi K, Brechbiel MW, Star RA (2002) Renal tubular damage detected by dynamic micro-MRI with a dendrimer-based magnetic resonance contrast agent. Kidney Int 61: 1980-1985
69. Hedlund LW, Maronpot RR, Johnson GA, Gofer GP, Mills GI, Wheeler CT (1991) Magnetic resonance microscopy of toxic renal injury induced by bromoethylamine in rats. Fundam Appl Toxicol 16: 787-797
70. Collinson PO, Boa FG, Gaze DC (2001) Measurement of cardiac troponins. Ann Clin Biochem 38: 423-449
71. Wassmuth R, Lentzsch S, Erdbruegger U, Schulz-Menger J, Doerken B, Dietz R, Friedrich MG (2001) Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging-a pilot study. Am Heart J 141: 1007-1013
72. Ochiai K, Ishibashi Y, Shimada T, Murakami Y, Inoue S, Sano K (1999) Subendocardial enhancement in gadolinium-diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging in aortic stenosis. Am J Cardiol 83: 1443-1446
73. Kitagawa Y, Yamashita D, Ito H, Takaki M (2004) Reversible effects of isoproterenol-induced hypertrophy on in situ left ventricular function in rat hearts. Am J Physiol Heart Circ Physiol 287: H277-H285
74. Slawson SE, Roman BB, Williams DS, Koretsky AP (1998) Cardiac MRI of the normal and hypertrophied mouse heart. Magn Reson Med 39: 980-987